Nutrient conditions which trigger sporulation also activate expression of the BaciUus licheniformis a-amylase gene, amyL. Glucose represses both spore formation and expression of amyL. A fusion was constructed between the B. licheniformis a-amylase regulatory and 5' upstream sequences (amyRi) and the Escherichia coli lacZ structural gene to identify sequences involved in mediating temporal activation and catabolite repression of the amyL gene in Bacillus subtilis. amyRi-directed expression in a variety of genetic backgrounds and under different growth conditions was investigated. A 108-base-pair sequence containing an inverted repeat sequence, ribosome-binding site, and 26 codons of the structural gene was sufficient to mediate catabolite repression of amyL. spoO mutations (spoOA, spoOB, spoOE, and spoOH) had no significant effect on temporal activation of the gene fusion when the recipient strains were grown in nonrepressing medium. However, in glucose-grown cultures the presence of a spoOA mutation resulted in more severe repression of amyRi-lacZ. In contrast, a spoOH mutatidn reduced the repressive effect of glucose on amyRi-lacZ expression. The spoOA effect was relieved by an abrB mutation. Initiation of sporulation is not a prerequisite for either temporal activation or derepression of a-amylase synthesis. Mutations causing resistance to catabolite repression in B. subtilis GLU-47, SF33, WLN30, and WLN104 also relieved catabolite repression of amyRi-lacZ.
The Bacillus licheniformis a-amylase gene, amyL, is temporally expressed and subject to catabolite repression both in its natural host and when cloned in Bacillus subtilis (16) . Catabolite repression is mediated at the level of transcription by sequences downstream from the promoter of amyL (16) .
In this report, the construction of a gene fusion of B. licheniformis a-amylase regulatory sequences to the Escherichia coli lacZ structural gene (amyRi-lacZ) is described. This fusion was used to determine more precisely the sequences necessary for mediating both temporal activation and catabolite repression of amyL.
amyL is temporally activated at the onset of the stationary phase under nonrepressing growth conditions, when cells presumably initiate sporulation. This suggests that the two processes are mechanistically related. spoO mutations block spoi-ulation prior to its earliest morphological event. They also inhibit the production of proteases (5, 8, 9, 29) and other stationary-phase-associated proteins such as phosphatases and extracellular antibiotics (12, 27) . It has now become evident that spoOA regulates not only sporulation-associated genes but also a variety of other genes (13, 18, 19) . SpoOA inhibits expression of hpr and abrB. Both of these genes appear to encode negative regulators which regulate expression of genes that are activated postexponentially in response to nutrient starvation (25, 26, 36) . spoOA is a positive regulator of spoOH (4, 7) . spoOH (sigH) encodes a minor vegetative sigma factor, aH (4, 7) . Expression of spoOH in strains carrying an abrB mutation is spoOA independent (7) . The data suggest that SpoOA has an important role as a sensory regulator in determining the regulation of global processes in the cell. Accordingly, it is of interest to study the effects of spoOA, abrB, spoOH, and other spoO tnutations on amyRi-directed expression.
To determine whether the mechanisms of catabolite repression of different enzyme systems share common regulatory pathways, we transformed the amyRi-lacZ gene into a B. subtilis mutant (GLU-47) resistant to catabolite repression in sporulation (28, 31, 32) and into three strains (SF33, WLN30, WLN104) which exhibit derepressed synthesis of certain enzymes normally subject to catabolite repression (10, 11 ; W. L. Nicholson, Ph.D. thesis, University of Wisconsin, Madison, 1987) . The expression of the gene fusion in these strains grown in repressing (1% glucose) and nonrepressing (no glucose) media was examined.
MATERIALS AND METHODS
Strains and culture conditions. The strains used in this study are listed in Table 1 . Strain S0113 is the amylasenegative strain used for the initial cloning of amyL. Strain JH642 is the parent strain from which the spoO mutations were isolated.
Protoplast transformation. Strain JH648 is not naturally competent; therefore, protoplasts were made as described previously (2) . Plasmid isolation. B. subtilis minipreparations were prepared as described previously (33) , and E. coli minipreparations were prepared by the method of Birnboim and Doly (1). Large-scale plasmid DNAs were prepared similarly except that the DNA was further purified by CsCl-ethidium bromide density gradient centrifugation (20 (16) .
The expression of amyRi-lacZ on a multicopy plasmid in B. siibtilis was examined. pDE37 carries a B. siibtilis origin of replication on a 3.7-kilobase EcoRI fragment from a cryptic plasmid, pBAA1, and a cat (chloramphenicol acetyltransferase) gene for selection in B. siubtilis (gift from K. Devine). This plasmid was digested with EcoRI, ligated to EcoRI-linearized pRB1, and transformed into B. suibtilis S0113, selecting for Em'r (5 p.g/ml). Some of the transformants carried only the 3.7-kilobase origin fragment ligated to pRB1 (pBL4), while others also carried the Cm`marker (pBL12) (Fig. 1) . Blue colonies were detectable on LB plus X-gal after 40 to 48 h. The center of the colony had a dark blue color which decreased in intensity to pale blue at the Expression of amyRi-lacZ in spoO backgrounds. spoO mutations arrest sporulation prior to its earliest morphological stage (stage 0), that is, the formation of an asymmetric septumtn. spoO genes are believed to be responsible for sensing nutritional signals and initiating response to environmental and nutrient conditions (18, 19) . It is known that spoO genes are also required for the development of competence, for antibiotic production (12) , and for the full expression of genes encoding the major proteases (5, 8, 9, 29) . We tested for an effect of spoO mutations on amyRi-lacZ expression. Strains harboring spoOA, spoOB, spoOE, or spoOH mutations were transformed with pBL12, which carries the amyRi-lacZ fusion (Fig. 1 ). Strains were grown in nonrepressing (no glucose) or repressing (1% glucose) media and assayed for intracellular 3-galactosidase activity. Strain JH642 is the parent strain from which the spoO mutations were isolated, and this strain was also transformed with pBL12. It is similar to S0113(pBL4). Synthesis of 3-galactosidase occurred maximally at the end of exponential growth and was subject to 10-fold repression in glucose-containing cultures (Fig. 3) .
When strains were grown under nonrepressing conditions, none of the spoO inutations affected temporal activation appreciably, though the spoOE-bearing strain [JH647 (pBL12)] had somewhat higher levels of P-galactosidase activity during vegetative growth than the isogenic Spo+ strain, JH642(pBL12) (Fig. 3) .
When grown in the presence of 1% glucose, JH648(pBL12), which carries a spoOB mutation, had low enzyme activity levels in the late stationary phase, two-to threefold lower than the repressed levels in Spo+ cultures (Fig. 3 ). It appears that the spoOB mutation exerts some effect on the expression of amyRi-lacZ in repressing medium. The spoOE mutation, however, had no significant effect on amyRi-directed expression in medium containing glucose (Fig. 3) ; repression in a spoOE background was unchanged from wild type. The gene products of spoOB and spoOE have not been identified. spoOB appears to have a vegetative function (3), while spoOE is induced before the onset of the stationary phase (24) . These genes may be involved, along with the spoOF gene product, in the conversion of the spoOA gene product from an inactive to an active form (24) .
The spoOH-bearing strain [JH651(pBL12)] was poorly repressed. As the cells entered the stationary phase, specific activity increased in a manner similar to the activity profile of cultures grown in the absence of glucose (Fig. 3) . Repression by glucose was only two-to fourfold. SpoOH has been identified as a sigma factor, aH (4, 7) . It is possible that the spoOH mutation prevents the transcription of a negative factor. The putative gene encoding this factor could have two promoters, a uH promoter sequence and a promoter recoghized by an alternate form of sigma factor, which would explain the low levels of glucose-mediated repression observed.
In contrast to JH651(pBL12), ,B-galactosidase activity in a spoOA-bearing mutant, JH646(pBL12), was repressed to a greater extent than in the Spo+ parent strain. The presence of glucose in the growth medium caused a severe and permanent repression of amyRi-lacZ expression-40-to 50-fold in the stationary phase. There was consistently fivefold-more repression of amyRi-lacZ expression in glucose-grown cultures of JH646(pBL12) compared with the Spo+ parent strain (Fig. 3) . spoOA is the most pleiotropic of all the spoO mutations and has been shown to be the site of suppressor mutations that allow sporulation to occur in the presence of defective spoOB, spoOE, and spoOF genes (24) . Perego and Hoch (24) suggested that the spoOA gene product acts as a transcriptional factor that interacts with RNA polymerase molecules containing minor forms of sigma factors. The reason for increased glucose-mediated repression of amyRi-lacZ expression in a spoOA background is not clear. It is possible that the absence of the spoOA gene product results in the failure of the cell to accurately sense its nutritional environment and consequently in its failure to respond in a manner similar to that of the wild-type strain under glucose-repressing growth conditions. A spoOA abrB double mutation relieves many spoOA effects, although these mutants are still sporulation negative (36) . The spoOA gene has recently been shown to repress transcription of the abrB gene (26) . abrB appears to encode a regulator involved in the control of a number of genes whose products are produced at the end of exponential growth. The abrB mutation relieved the severe repression of amyRi-lacZ exerted by spoOA and restored repression to Spo+ levels (Fig. 3) .
Strains carrying spoO mutations are defective in sporula- sis. Mutations have been isolated which allow sporulation to occur in the presence of glucose but which do not derepress enzyme synthesis (6, 14) , and conversely there are mutants which are catabolite repression resistant for the synthesis of one or more enzymes (10, 11 ; Nicholson, Ph.D. thesis) but which do not sporulate in glucose-containing medium.
A number of catabolite repression-resistant mutants have been isolated which exhibit more pleiotropic phenotypes and are resistant to glucose-mediated repression of both sporulation and of a number of enzymes tested (30) (31) (32) . One of these strains, GLU-47, carries a mutation, crsA47 (rpoD47), in the rpoD (sigA) locus (28) . crsA47 relieves catabolite repression of sporulation and also of the enzymes acetoin dehydrogenase (32) and gluconate kinase (15) . GLU-47 was transformed with pBL12 ( Fig. 1) . GLU-47(pBL12) was then grown in nonrepressing or repressing (1% glucose) media and assayed for P-galactosidase activity. The activity profile of P-galactosidase in cultures grown in the presence of glucose was similar to the pattern of ,B-galactosidase activity in nonrepressing medium (Fig. 4) . The presence of glucose in the growth medium did not significantly repress amyRi-lacZ expression in GLU-47. Thus, crsA47 relieves not only catabolite repression of sporulation but also repression of a gene under the control of amyRi. The alteration of crA caused by crsA47 also restores the ability to sporulate to strains carrying spoOE, spoOF, and spoOK mutations (15, 17) . 0.A, which is the predominant sigma factor in vegetatively growing cells, therefore plays a vital role in the initiation of sporulation and in the regulation of genes subject to glucosemediated repression. Price and Doi (28) have suggested that the crsA47 mutation alters cA so that it no longer requires certain nutritional signals or spoO functions to initiate transcription of sporulation-specific or sporulation-associated genes.
The activity profile of P-galactosidase from GLU-47 (pBL12) differed from the activity profile of the wild-type strains S0113(pBL4) (Fig. 2) and JH642(pBL12) (Fig. 3) . In exponentially growing cultures of GLU-47(pBL12), the level of P-galactosidase activity was two-to threefold higher than wild-type levels (Fig. 4) . However, the amount of activity in late-stationary-phase cultures (T3) of GLU-47(pBL12) was similar to wild-type levels. amyRi-lacZ does not appear to be temporally activated to the same extent in the mutant strain as in the wild-type strains. The mechanism of temporal activation of amyL is not understood. It appears to be transcribed by the major vegetative RNA polymerase, EUrA (16) . This suggests that postexponential activation of amyL is not due to the appearance of a new form of RNA polymerase holoenzyme. The increased 3-galactosidase activity found in exponentially growing cells harboring crsA47 suggests a possible role for sigA in modulating expression of amyL.
Fisher and Magasanik (10) isolated a mutant, SF33 (carrying a cdh-3 mutation), which exhibited derepressed levels of histidase, cx-glucosidase, and aconitase when grown on catabolite repressing medium. SF33 showed reduced levels of pyruvate, oxaloacetate and 2-ketoglutarate similar to the levels in wild-type cells growing under nonrepressing conditions. 1-Galactosidase activity profiles of an isogenic cdh+ strain, SF32(pBL12), were similar to those of strain JH642(pBL12) under all growth conditions (data not shown). amyRi-lacZ expression was temporally activated (as wild type) in SF33(pBL12) (Fig. 4) . However, cultures of SF33(pBL12) grown in the presence of glucose showed partially derepressed levels of 3-galactosidase as compared with SF32(pBL12). The levels of P-galactosidase were fourto fivefold higher (Fig. 4) than in SF32(pBL12) . The enzymes studied by Fisher and Magasanik (10) are closely involved with the glycolytic pathway; therefore, the possibility that the pleiotropic effects were simply due a defect in this pathway could not be ruled out. The fact that the cdh-3 mutation causes derepression of amyRi-lacZ provides some evidence that the cdh-3 mutation is involved in relieving catabolite repression of enzyme synthesis. However, amyRi-lacZ expression was only partially derepressed, which suggests that the gene product encoded by the cdh-3 gene is one of a number of proteins involved, directly or indirectly, in mediating catabolite repression of catabolic enzyme systems.
Mutations which partially relieve glucose-mediated repression of B. subtilis amyE gene expression were isolated by Tn917 insertional mutagenesis (Nicholson, Ph.D. thesis). These mutations did not affect sporulation initiation. One of these mutants, WLN30, carries the gra-26::Tn917 insertion, which maps to the aroG-argA region of the chromosome and is likely to be an insertion within the alsA gene. The role of alsA is unclear, but it appears to be a positive regulator of alsR-alsS, which encodes acetolactate synthase (34) . The expression of amyRi-lacZ in WLN30(pBL12) was fivefold higher than that of the wild type in exponentially growing cultures growing in both repressing and nonrepressing media. ,B-Galactosidase activity increased only two-to threefold in the stationary phase. There was partial repression of enzyme activity when WLN30(pBL12) was grown in the presence of 1% glucose. 1-Galactosidase production was reduced 2-to 3-fold in cultures grown in medium containing 
